CAS No.: | 90098-04-7 |
EINECS | 213-580-7 |
Content: | ≥ 99.0% |
Appearance: | A white,Crystalline Powder or colorless crystals |
Formula: | C19H15ClN2O4 |
Molecular Weight | 370.7864 |
1-1000 Kilogram: | $495.00 |
≥ 1001 Kilogram: | $480.00 |
Name: Rebamipide | |
CAS No.: | 90098-04-7 |
EINECS | 213-580-7 |
Content: | ≥ 99.0% |
Appearance: | A white,Crystalline Powder or colorless crystals |
Formula: | C19H15ClN2O4 |
Molecular Weight | 370.7864 |
Moisture: | ≤0.1% |
Loss on Drying: | ≤0.2% |
Residue on ignition: | ≤0.1% |
Melting Point: | 160°C~166°C |
Heavy Metals: | ≤10PPM |
Acidity or Alkalinity: | Conform |
Chloride: | Conform |
Readily Carbonizable Substances: | Conform |
Ordinary Impurities: | Conform |
Packing: | 25KG net fiber drum lined with plastic bag. |
Rebamipide an amino acid derivative of 2-(1H)-quinolinone, is used for mucosal protection, healing of gastroduodenal ulcers, and treatment of gastritis. It works by enhancing mucosal defense, scavenging free radicals, and temporarily activating genes encoding cyclooxygenase-2.
Rebamipide is used in a number of Asian countries including Japan, South Korea, and China. Studies have shown that rebamipide can fight the damaging effects of NSAIDs on the GIT mucosa, and more recently, the small intestine.
It has also been studied for the treatment of Behçet’s disease.
It was shown to successfully treat pouchitis in a single-N study after first line therapies for the condition were unsuccessful.
Some studies have shown effectiveness in presbyacusis (age-related hearing loss).
It has also been shown to alleviate signs and symptoms of dry eyes in a randomised controlled trial although this is not yet widely available clinically.
Only logged in customers who have purchased this product may leave a review.
There are no reviews yet.